Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Revenue

Aligned Genetics had revenue of 4.35B KRW in the quarter ending June 30, 2026, with 10.89% growth. This brings the company's total for the last twelve months to 16.16B, down -5.88% year-over-year. In the year 2025, Aligned Genetics had annual revenue of 16.02B with 1.51% growth. That makes Aligned Genetics the 36,464th largest company in the world by revenue and 2,335th in South Korea.

• Revenue (ttm): 16.16B
• Revenue Growth: -5.88%
• P/S Ratio: 2.26
• Revenue / Employee: 252.54M
• Employees: 64
• Market Cap: 36.54B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 7.62B 47.6%
• United States of America (USA) 5.25B 32.8%
• France 3.05B 19.0%
• Japan 99.02M 0.6%

Fiscal year ended Dec 31, 2025 See the full Aligned Genetics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	16.02B	238.34M	1.51%
Dec 31, 2024	15.78B	562.88M	3.70%
Dec 31, 2023	15.21B	1.46B	10.63%
Dec 31, 2022	13.75B	1.99B	16.92%
Dec 31, 2021	11.76B	3.80B	47.82%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error